A Phase II Study Of Genistein In Patients With Localized Prostate Cancer (Molecular Correlates of Soy In Humans)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Genistein (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Biomarker; Pharmacodynamics
Most Recent Events
- 19 Jul 2012 Biomarkers information updated
- 20 May 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 May 2011 Planned end date changed from 1 Dec 2012 to 1 Sep 2009 as reported by ClinicalTrials.gov.